On the Versatility of Nanozeolite Linde Type L for Biomedical Applications: Zirconium-89 Radiolabeling and In Vivo Positron Emission Tomography Study.
multimodal imaging
nanozeolites
positron emission tomography (PET)
radiolabeling
radiopharmaceuticals
zirconium-89
Journal
ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991
Informations de publication
Date de publication:
13 Jul 2022
13 Jul 2022
Historique:
entrez:
13
7
2022
pubmed:
14
7
2022
medline:
14
7
2022
Statut:
aheadofprint
Résumé
Porous materials, such as zeolites, have great potential for biomedical applications, thanks to their ability to accommodate positively charged metal-ions and their facile surface functionalization. Although the latter aspect is important to endow the nanoparticles with chemical/colloidal stability and desired biological properties, the possibility for simple ion-exchange enables easy switching between imaging modalities and/or combination with therapy, depending on the envisioned application. In this study, the nanozeolite Linde type L (LTL) with already confirmed magnetic resonance imaging properties, generated by the paramagnetic gadolinium (Gd
Identifiants
pubmed: 35830285
doi: 10.1021/acsami.2c03841
pmc: PMC9335405
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Bioconjug Chem. 2009 May 20;20(5):825-41
pubmed: 19125647
ACS Appl Mater Interfaces. 2020 Jul 15;12(28):31137-31147
pubmed: 32551479
ACS Nano. 2021 Feb 23;15(2):3212-3227
pubmed: 33470092
Nanoscale Res Lett. 2015 Dec;10(1):956
pubmed: 26058517
Chemistry. 2014 Mar 17;20(12):3358-64
pubmed: 24523192
Molecules. 2019 Apr 18;24(8):
pubmed: 31003494
ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23458-23465
pubmed: 28657291
Theranostics. 2020 Jun 25;10(17):7921-7924
pubmed: 32685029
J Control Release. 2012 Oct 10;163(1):46-54
pubmed: 22684119
J Control Release. 2021 Feb 10;330:726-737
pubmed: 33428985
Arch Toxicol. 2010 Mar;84(3):183-90
pubmed: 19936708
Mol Imaging Biol. 2015 Aug;17(4):539-47
pubmed: 25500766
Acc Chem Res. 2018 Mar 20;51(3):778-788
pubmed: 29489335
Nucl Instrum Methods Phys Res A. 2011 Aug 21;648 Supplement 1:S236-S240
pubmed: 21804677
Nanoscale. 2020 Jan 23;12(3):1759-1778
pubmed: 31895375
ACS Nano. 2015 Aug 25;9(8):7950-9
pubmed: 26213260
Nucl Med Biol. 2011 Jul;38(5):675-81
pubmed: 21718943
Nano Lett. 2015 Feb 11;15(2):864-8
pubmed: 25559467
Nucl Med Biol. 2009 Oct;36(7):729-39
pubmed: 19720285
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45
pubmed: 16832633
Dalton Trans. 2014 Jul 14;43(26):9872-84
pubmed: 24722728
Nanomedicine (Lond). 2008 Oct;3(5):703-17
pubmed: 18817471
Chem Sci. 2015 Jan 1;6(1):225-236
pubmed: 28553472
Biomed Res Int. 2014;2014:203601
pubmed: 24991539
Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S10-8
pubmed: 21484385
Mol Pharm. 2008 Jul-Aug;5(4):496-504
pubmed: 18611037
Nanoscale. 2014 May 7;6(9):4928-35
pubmed: 24675844
Acta Pharmacol Sin. 2017 Jun;38(6):907-913
pubmed: 28414201
Bioconjug Chem. 2017 Sep 20;28(9):2211-2223
pubmed: 28767228
Adv Sci (Weinh). 2016 May 27;3(11):1600122
pubmed: 27980987
ACS Nano. 2010 Jan 26;4(1):342-8
pubmed: 20020752